MARTINETI, VALENTINA
MARTINETI, VALENTINA
MEDICINA INTERNA (attivo dal 01/01/1999 al 31/12/2012)
Allelic loss in parathyroid tumors from individualshomozygous for multiple endocrine neoplasia type 1.
1997 Falchetti A; Morelli A; Amorosi A; Tonelli F; Fabiani S; Martineti V; Castello R; Furlani L; Brandi ML.
Characterization of the functional and growth properties of long-term cell cultures established from a human somatostatinoma
2006 GALLI G; ZONEFRATI R; GOZZINI A; MAVILIA C; MARTINETI V; TOGNARINI I; NESI G; MARCUCCI T; TONELLI F; TOMMASI M; RAGGI CC; PINZANI P; M.L. BRANDI
ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components
2005 V. MARTINETI; L. PICARIELLO; I. TOGNARINI; S. SALA CARBONELL; A. GOZZINI; C. AZZARI; C. MAVILIA; A. TANINI; A. FALCHETTI; G. FIORELLI; F. TONELLI; M.L. BRANDI
Genetics and pharmacogenetics of estrogen response
2007 CARBONELL SALA S; MARTINETI V; CAROSSINO A.M.; BRANDI M.L
Haplotype analysis of two pairs of unrelated Italian families affected by Paget's disease of bone, exhibiting different geographical origins and two different mutations of p62/sequestosomel gene, supports the evidence for common founders.
2006 A. Falchetti;M. D. Stefano;F. Marini;L. Masi;F. Giusti;C. Cepollaro;E. Luzi;V. Martineti;C. Mavilia;D. Strigoli;S. Bergui;G. Isaia;M. L. Brandi
Heterogeneity of binding sites and bioeffects of raloxifene on the human leukemic cell line FLG 29.1.
1997 G. Fiorelli; V. Martineti; F. Gori; S. Benvenuti; U. Frediani; L. Formigli; S. Zecchi; M. L. Brandi
In vitro effects of oestrogens, antioestrogens and SERMs on pancreatic solid pseudopapillary neoplasm-derived primary cell culture.
2010 I.Tognarini; F.Tonelli; G.Nesi; V.Martineti; G.Galli; A.Gozzini; E.Colli; R.Zonefrati; M.Paglierani; F.Marini; S.Sorace; T.Cavalli; L.Cavalli; A.Tanini; M.L.Brandi
Isolamento e caratterizzazione di batteri cellulosolitici dall'apparato digerente di anfipodi talitridi
1995 V. Martineti; E. Gallori; B. Perito; A. Ugolini
MEN1 gene mutation analysis in Italian patients with multiple endocrineneoplasia type 1.
2000 Morelli A; Falchetti A; Martineti V; Becherini L; Mark M; Friedman E; Brandi ML.
Methodological models for in vitro amplification and maintenance of human articular chondrocytes from elderly patients
2007 Carossino, Anna Maria; Recenti, Raffaella; Carossino, Roberto; Piscitelli, Elisabetta; Gozzini, Alessia; Martineti, Valentina; Mavilia, Carmelo; Franchi, Alessandro; Danielli, Daniele; Aglietti, Paolo; Ciardullo, Antonio; Galli, Gianna; Tognarini, Isabella; Moggi Pignone, Alberto; Cagnoni, Mario; Brandi, Maria Luisa
Telomerase repeat amplificationprotocol (TRAP): A new molecular marker for parathyroid carcinoma.
1999 Falchetti A; Becherini L; Martineti V; Morelli A; Benvenuti S; Picariello L; Gennari L; Lampugnani R; Bordi C; Brandi ML.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Allelic loss in parathyroid tumors from individualshomozygous for multiple endocrine neoplasia type 1. | 1997 | Falchetti A; Morelli A; Amorosi A; Tonelli F; Fabiani S; Martineti V; Castello R; Furlani L; Brandi ML. | |
| Characterization of the functional and growth properties of long-term cell cultures established from a human somatostatinoma | 2006 | GALLI G; ZONEFRATI R; GOZZINI A; MAVILIA C; MARTINETI V; TOGNARINI I; NESI G; MARCUCCI T; TONELLI F; TOMMASI M; RAGGI CC; PINZANI P; M.L. BRANDI | |
| ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components | 2005 | V. MARTINETI; L. PICARIELLO; I. TOGNARINI; S. SALA CARBONELL; A. GOZZINI; C. AZZARI; C. MAVILIA; A. TANINI; A. FALCHETTI; G. FIORELLI; F. TONELLI; M.L. BRANDI | |
| Genetics and pharmacogenetics of estrogen response | 2007 | CARBONELL SALA S; MARTINETI V; CAROSSINO A.M.; BRANDI M.L | |
| Haplotype analysis of two pairs of unrelated Italian families affected by Paget's disease of bone, exhibiting different geographical origins and two different mutations of p62/sequestosomel gene, supports the evidence for common founders. | 2006 | A. Falchetti;M. D. Stefano;F. Marini;L. Masi;F. Giusti;C. Cepollaro;E. Luzi;V. Martineti;C. Mavilia;D. Strigoli;S. Bergui;G. Isaia;M. L. Brandi | |
| Heterogeneity of binding sites and bioeffects of raloxifene on the human leukemic cell line FLG 29.1. | 1997 | G. Fiorelli; V. Martineti; F. Gori; S. Benvenuti; U. Frediani; L. Formigli; S. Zecchi; M. L. Brandi | |
| In vitro effects of oestrogens, antioestrogens and SERMs on pancreatic solid pseudopapillary neoplasm-derived primary cell culture. | 2010 | I.Tognarini; F.Tonelli; G.Nesi; V.Martineti; G.Galli; A.Gozzini; E.Colli; R.Zonefrati; M.Paglierani; F.Marini; S.Sorace; T.Cavalli; L.Cavalli; A.Tanini; M.L.Brandi | |
| Isolamento e caratterizzazione di batteri cellulosolitici dall'apparato digerente di anfipodi talitridi | 1995 | V. Martineti; E. Gallori; B. Perito; A. Ugolini | |
| MEN1 gene mutation analysis in Italian patients with multiple endocrineneoplasia type 1. | 2000 | Morelli A; Falchetti A; Martineti V; Becherini L; Mark M; Friedman E; Brandi ML. | |
| Methodological models for in vitro amplification and maintenance of human articular chondrocytes from elderly patients | 2007 | Carossino, Anna Maria; Recenti, Raffaella; Carossino, Roberto; Piscitelli, Elisabetta; Gozzini, Alessia; Martineti, Valentina; Mavilia, Carmelo; Franchi, Alessandro; Danielli, Daniele; Aglietti, Paolo; Ciardullo, Antonio; Galli, Gianna; Tognarini, Isabella; Moggi Pignone, Alberto; Cagnoni, Mario; Brandi, Maria Luisa | |
| Telomerase repeat amplificationprotocol (TRAP): A new molecular marker for parathyroid carcinoma. | 1999 | Falchetti A; Becherini L; Martineti V; Morelli A; Benvenuti S; Picariello L; Gennari L; Lampugnani R; Bordi C; Brandi ML. |